The global allergy immunotherapy market size is expected to reach USD 3.1 billion by 2027 registering a CAGR of 9.0%, according to a new report by Grand View Research, Inc. Rising prevalence of allergic conditions is expected to boost the market growth. According to the statistics published by the American Academy of Allergy, Asthma & Immunology (AAAAI), global prevalence of allergic rhinitis ranges from 10% to 30%. The disease affects 7.8% of the adult population in U.S. alone.
Technological
advancements in the field of bioengineering and immunology have improved the
composition of allergy shots given to patients for boosting the immune system.
In addition, efforts to overcome the problems associated with safety, efficacy,
standardization, costs, and long duration of immunotherapy is also expected to
propel the market growth in the coming years. Europe occupied the largest
market share in 2019 and will retain its leading position during the forecast
period. However, Asia Pacific is estimated to be the fastest-growing regional
market from 2020 to 2027.
Full Research Report On Allergy Immunotherapy Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/allergy-immunotherapy-market
Allergy
Immunotherapy Market Report Highlights
- Subcutaneous Immunotherapy
(SCIT) segment generated the maximum revenue in 2019 as SCIT is the most
effective and highly adopted form of allergy immunotherapy
- SCIT can be used for the
treatment of a wide range of disorders including allergic rhinitis,
asthma, and stinging insect hypersensitivity
- However, Sublingual
Immunotherapy (SLIT) has emerged as a safe & effective alternative for
SCIT
- During SLIT, the allergen is
administered under the tongue in the form of tablets or drops
- Allergic rhinitis was the
largest revenue-generating segment in 2019 and is estimated to maintain
its dominance throughout the forecast period owing to the high disease
burden across the globe
- Hospital pharmacy segment
held the largest share in 2019 owing to a rise in the patient pool for
treatment of allergic disorders in hospitals
- ASIT Biotech; Circassia;
Mylan N.V.; Adamis Pharmaceuticals Corp.; Merck KGaA; Stallergenes Greer
plc.; Allergy Therapeutics; ALK-Abelló A/S; DESENTUM OY; HAL Allergy B.V.;
HollisterStier Allergy; LETIPharma; and DBV Technologies SA are the
prominent participants operating in this market
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/allergy-immunotherapy-market/request/rs1
Allergy
Immunotherapy Market Segmentation
Grand View Research has segmented
the global allergy immunotherapy market on the basis of treatment type, allergy
type, distribution channel, and region:
Allergy
Immunotherapy Treatment Type Outlook (Revenue, USD Million, 2016 - 2027)
- Subcutaneous Immunotherapy
(SCIT)
- Sublingual Immunotherapy
(SLIT)
- Tablets
- Drops
Allergy
Immunotherapy Allergy Type Outlook (Revenue, USD Million, 2016 - 2027)
- Allergic Rhinitis
- Allergic Asthma
- Others
Allergy
Immunotherapy Distribution Channel Outlook (Revenue, USD Million, 2016 - 2027)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Allergy
Immunotherapy Regional Outlook (Revenue, USD Million, 2016 - 2027)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- Asia Pacific
- Japan
- China
- Latin America
- Brazil
- Mexico
- MEA
- South Africa
- Saudi Arabia
List of Key Players
of Allergy Immunotherapy Market
- ASIT Biotech
- Circassia
- Mylan N.V.
- Adamis Pharmaceuticals
Corporation
- Merck KGaA
- Stallergenes Greer plc
- Allergy Therapeutics
- ALK-Abelló A/S
- DESENTUM OY
- HAL Allergy B.V.
- HollisterStier Allergy
- LETIPharma
- DBV Technologies SA
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment